What's New

Coya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy

Coya Therapeutics announced positive interim results for its clinical trial for a potentially disease-modifying treatment course for FTD, citing data showing that it helped to prevent cognitive decline. Therapeutics Address…

Read More about Coya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy

AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference

Gene therapy company AviadoBio announced the completion of the second cohort of its phase 1/2 clinical trial of a potential genetic FTD treatment at the 2025 AFTD Annual Education Conference…

Read More about AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference

Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock…

Read More about Celebrating 20 Years of AFTD’s Pilot Grant Program

Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock…

Read More about Celebrating 20 Years of AFTD’s Pilot Grant Program

Advancing Hope: FTD and ALS Joint Initiatives

Did you know that certain cellular changes that occur in FTD are also observed in Amyotrophic Lateral Sclerosis (ALS)? In some cases, neurodegeneration in ALS and FTD is linked to…

Read More about Advancing Hope: FTD and ALS Joint Initiatives

The Lived Experience of FTD: Managing Anxiety

The following article was written by Chris Tann, a member of AFTD’s Persons With FTD Advisory Council. You can learn more about Chris and the other members of the Council…

Read More about The Lived Experience of FTD: Managing Anxiety

Two Drugs Selected for Evaluation in Platform Trial for PSP

A pair of drugs has been selected for evaluation in a platform trial that aims to accelerate the development of treatments for progressive supranuclear palsy (PSP). The trial is being…

Read More about Two Drugs Selected for Evaluation in Platform Trial for PSP

Dear HelpLine: Hospice Care and FTD

Dear HelpLine, My sister has had FTD for a few years, and her doctor recently told us we should consider moving her to hospice. What does hospice care involve? How…

Read More about Dear HelpLine: Hospice Care and FTD

Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses

A study published in the journal Alzheimer’s & Dementia evaluates the potential utility of a novel PET tracer for progressive supranuclear palsy (PSP) while also exploring how the disorder damages…

Read More about Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses

Former Judge Gains Artistic Ability after PPA Diagnosis

A former judge in Folsom, Calif., has discovered a newfound talent for visual art following a diagnosis of primary progressive aphasia, KCRA in Sacramento reported earlier this year. Two years…

Read More about Former Judge Gains Artistic Ability after PPA Diagnosis